Ann: PromarkerD diabetic kidney disease patent granted in Japan, page-16

very good question. I think because such a large percentage of the register is held by the founders and cornerstones who are entirely aware of and comfortable with their investment they aren't particularly interested in spruiking and probably are confident that the value will be realised in due course. Think about it. The MC is 17 mil not including options, the founders and cornerstones are I can't remember but definitely more than half of it. They simply not interested in the machinations of the market day to day. In this company's case we retailers are on the ride because a bit more capital to get to the endgame was needed.. I guess the feel that well get our reward when they do, end of story.. back to building a disruptive biotech and obscene wealth.

I would love to learn of another company with such a low MC and risk/reward profile.